VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
ST. GALLEN, Switzerland -- (BUSINESS WIRE) -- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the Eu......

